Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

NCT03100877 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Feasibility Issues

Conditions

Plasma Cell Leukemia in Remission
Plasma Cell Myeloma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
BIOLOGICAL: Filgrastim
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
PROCEDURE: pheresis
DRUG: Melphalan
BIOLOGICAL: Palifermin
RADIATION: Total Marrow Irradiation

Sponsor

City of Hope Medical Center

Collaborators

[object Object]